Senior Director, Bioanalytical and Biomarker Science and Technologies
Takeda
Heather Myler received her PhD in 2002 from Rice University, Houston, Texas and has held positions of increasing responsibility in the pharmaceutical industry supporting regulated bioanalysis including pharmacokinetic, immunogenicity and biomarker testing. She currently serves as Senior Director in Bioanalytical and Biomarker Science and Technologies and the Head of Immunogenicity and New Modalities at Takeda Pharmaceuticals. She has a strong external scientific presence, serving on the American Association of Pharmaceutical Scientists Editorial Board, Scientific Advisory Committee and actively participating in programming and presentation at a wide array of national conferences. Heather is a catalyst for organizational and strategic growth with a strong mix of scientific, operational, and regulatory experience, coupled with an entrepreneurial spirit. She has a proven track record in driving business strategies focusing on innovation and differentiated laboratory technology and is a key advisor and collaborative relationship builder across teams.
Rapid Fires: Approaches for Emerging Modalities and Complex Studies 1
Tuesday, October 24, 2023
3:00 PM – 4:00 PM ET
Innovative Immunogenicity Strategies for New Modalities
Tuesday, October 24, 2023
3:15 PM – 3:30 PM ET